Depression

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depression Trial in United States (Pharmacogenetic testing, Clinical decisions support)

Recruiting
  • Depression
  • Pharmacogenetic testing
  • Clinical decisions support
  • Wilmington, Delaware
  • +13 more
Jul 21, 2023

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Little Rock, Arkansas
  • +73 more
Jan 10, 2019

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)

Completed
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +143 more
Sep 14, 2018

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (Placebo + ADT, Brexpiprazole +ADT)

Completed
  • Depressive Disorder
  • +4 more
  • Placebo + ADT
  • Brexpiprazole +ADT
  • Birmingham, Alabama
  • +46 more
Aug 17, 2018

Depression, Anxiety Trial in United States (IDgenetix Neuropsychiatric Test Panel)

Completed
  • Depression
  • Anxiety
  • IDgenetix Neuropsychiatric Test Panel
  • Rolling Hills, California
  • +16 more
Dec 16, 2016

Sexual Dysfunctions, Psychological, Depression Trial in United States (flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs,

Terminated
  • Sexual Dysfunctions, Psychological
  • Depression
  • flibanserin 50 mg to 100 mg qhs
  • +2 more
  • Costa Mesa, California
  • +41 more
Jul 14, 2016

Anxiety Disorder, Depression, Fatigue Trial in Puerto Rico, United States (cisplatin, fluoxetine, gemcitabine HCl)

Completed
  • Anxiety Disorder
  • +3 more
  • Anniston, Alabama
  • +42 more
Jul 1, 2016

Depression Trial in United States (Armodafinil, Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +39 more
Apr 26, 2016

Depression Trial in Worldwide (Armodafinil, Placebo)

Completed
  • Depression
  • Birmingham, Alabama
  • +91 more
Apr 26, 2016

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712 + ADT, Placebo + ADT)

Completed
  • Depressive Disorder
  • +4 more
  • OPC-34712 + ADT
  • Placebo + ADT
  • Arcadia, California
  • +56 more
Oct 26, 2015

Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)

Terminated
  • Depression
  • Birmingham, Alabama
  • +143 more
Sep 23, 2015

Depression Trial in Worldwide (Duloxetine, Placebo matching with BMS-820836, BMS-820836)

Completed
  • Depression
  • Little Rock, Arkansas
  • +83 more
Sep 23, 2015

MDD, Depression Trial in India, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • Depression
  • Tuscaloosa, Alabama
  • +50 more
Mar 14, 2014

MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • +2 more
  • Birmingham, Alabama
  • +93 more
Mar 14, 2014

MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

Completed
  • Major Depressive Disorder
  • Depression
  • Birmingham, Alabama
  • +98 more
Mar 14, 2014

Smoking Cessation, Depression Trial in Worldwide (varenicline, )

Completed
  • Smoking Cessation
  • Depression
  • Garden Grove, California
  • +40 more
Mar 6, 2013